AbbVie Inc. (NYSE:ABBV) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.
AbbVie Inc. (NYSE:ABBV) gained 0.83 Percent and closed its previous trading session at $105.04. The stock traded with the average Volume of 7.17 Million at the end of last session.
The company reported its last earnings Actual EPS of $1.87/share. While, the analyst predicted that the company could provide an EPS of $1.79/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.08/share which shows an Earnings Surprise of 4.5 Percent.
Sell side analysts plays vital role in buying and selling a stock where 4 analysts rated AbbVie Inc. (NYSE:ABBV) as Buy, 0 analysts given Outperform signal, 5 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 6.68% where SMA50 and SMA200 are 4.33% and 9.81% respectively.
The company shows its Return on Assets (ROA) value of 9.2%. The Return on Equity (ROE) value stands at 119.3%. While it’s Return on Investment (ROI) value is 25.4%.
AbbVie Inc. (NYSE:ABBV) currently has a Weekly Volatility of 1.92% percent while its Monthly Volatility is at 2.32% percent. While talking about Performance of the Stock, AbbVie Inc. currently has a Weekly performance of 3.81%, monthly performance percentage is 12.23 percent, Quarterly performance is -7.11 percent, 6 months performance shows a percent value of 10.43% and Yearly Performance is 57.13 percent.
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie aims to help patients’ live healthier lives and collaborate on sustainable healthcare solutions.